| Wellcare Wyoming Medicare Clinical | V1.2025 Concert Genetics Oncology: Circulating Tumor DNA and Circulating Tumor Cells (Liquid Biopsy) | 2024-11-01 |
| Wellcare Wyoming Medicare Clinical | V1.2025 Concert Genetics Oncology: Cytogenetic Testing | 2024-11-01 |
| Wellcare Wyoming Medicare Clinical | Concert Genetic Testing Oncology: Molecular Analysis of Solid Tumors and | 2024-11-01 |
| Medicare Palmetto | Billing and Coding: MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) (56899) | 2024-10-31 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Gender Affirmation Treatment | 2024-10-28 |
| Presbyterian Health Plan | Durable Medical Equipment: Respiratory Devices | 2024-10-23 |
| Presbyterian Health Plan | Tonsillectomy | 2024-10-23 |
| Meridian Illinois Medicaid Clinical | Betamethasone Dipropionate Spray | 2024-10-22 |
| Meridian Illinois Medicaid Clinical | Doxepin (Silenor) | 2024-10-22 |
| Meridian Illinois Medicaid Clinical | Linaclotide (Linzess) | 2024-10-22 |